Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synbiotic prophylaxis after colorectal cancer surgery
DRKS00034919Phase 3Recruiting
- Sponsor
- German Cancer Research Center
- Start
- Nov 2024
- Modality
- Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of inulin in colorectal cancer (CRC), colon cancer, rectosigmoid cancer and 1 more (2 arms), sponsored by German Cancer Research Center. Primary endpoint: Lower gastrointestinal symptom burden. Started Nov 2024; status: recruiting.
02
Drugs
inulin
03
Conditions
colorectal cancer (CRC)colon cancerrectosigmoid cancerrectal cancer
Beyond the preview
Go deeper on DRKS00034919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00034919.